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In Brief E et al. reveal an unexpected function of antimicrobial peptides as the signal molecule to trigger aging-and infectionassociated dendrite degeneration and show that an epidermally expressed antimicrobial peptide can activate a conserved neuronal GPCR to cause dendrite degeneration through autophagic machinery.
INTRODUCTION
Neurons have reciprocal regulatory interactions with surrounding cells. The innate immune system, as well as many molecules with immune functions, plays important roles in the nervous system (Boulanger, 2009; Stephan et al., 2012) . Recent studies show that the dramatic increase of C1q, the pattern recognition molecule of the classical complement cascade that functions in the innate immune system to remove pathogens upon infections, triggers the functional aging of the brain (Sekar et al., 2016; Stephan et al., 2013) . Whereas the reason for the increased expression of such immune molecules in the aging brain is still unknown, studies have implicated that sporadic Alzheimer's disease (AD) is associated with infections by pathogenic microbes, such as fungi, herpes simplex virus, and pneumonia-causing Chlamydophila pneumonia (Hill et al., 2014) . However, it remains unclear whether infections cause the degeneration of neurons and whether any immune molecules that can be induced by infections contribute to aging-associated neurodegeneration.
Antimicrobial peptides (AMPs) are host-defense peptides and play important roles in fighting microbe pathogens after infections (Zhang and Gallo, 2016) . Emerging evidence shows that some AMPs are highly expressed in mouse microglia (Hickman et al., 2013) as well as in the astrocytes of AD patients' brains (Williams et al., 2013) despite the absence of infection, suggesting that AMPs may have non-antimicrobial functions in the nervous system.
Dendrite and axon degeneration occur in both normal aging and aging-related neurodegenerative diseases and are considered major causes of neuronal dysfunction (Adalbert and Coleman, 2013; Dickstein et al., 2007; Lin and Koleske, 2010) . Studies have revealed factors involved in the regulation of axon degeneration , whereas the mechanisms underlying dendrite degeneration remain largely unknown.
Here, using C. elegans PVD neurons as a model, we show that aging-associated expression of NLP-29 (neuropeptide-like protein 29), an epidermally expressed AMP (Couillault et al., 2004; Pujol et al., 2008a) , causes dendrite degeneration. We further identify a conserved orphan G protein-coupled receptor (GPCR) NPR-12 (neuropeptide receptor 12) as the receptor in neurons for NLP-29 and show that NPR-12 signaling induces autophagy to mediate aging-associated dendrite degeneration. Moreover, we find that fungal infections can induce dendrite LGG-1) and dendrite degeneration-associated bead-or bubble-like structures (mCherry::PH/membrane-bound mCherry) in the PVD neuron of control animals. A mutant form of LGG-1 (G116A) that does not have the ability to localize to autophagosomes was used as a negative control (Manil-Sé galen et al., 2014) . The scale bars represent 10 mm. (C) Quantification of PVD dendrite degeneration and the mortality (death) rate in control animals (wdIs51). For each experiment, the percentage was calculated by the number of animals having dendrite degeneration divided by the total number of animals observed. The error bar indicates ± SEM among the three experiments performed for each time point.
(legend continued on next page) degeneration through the same mechanism as in aging. Finally, we present evidence to show that NLP-29/AMP can cause dendrite degeneration in NPR-12-expressing rat cortical neurons through the autophagic machinery as well, suggesting that the findings we report here are likely to be evolutionarily conserved. Therefore, our study uncovers an unexpected novel function of NLP-29/AMP and its neuronal receptor in regulating dendrite degeneration and provides a new mechanism for dendrite degeneration in physiological and pathological conditions.
RESULTS

PVD Neurons Exhibit Aging-Associated Dendrite Degeneration
To investigate aging-associated neurodegeneration in vivo, we used C. elegans PVD neurons as a model. Each of the two PVD neurons, PVDL and PVDR, has extensive, highly branched, and well-organized dendritic arbors, with one ventrally oriented axon ( Figure 1A ; Smith et al., 2010) . First, we characterized the PVD degeneration pattern during aging by observing the changes of dendrite morphology in control animals (wdIs51(F49H12.4::GFP)) from day 1 to day 9 of adulthood consecutively, with day 1 defined as 24 hr after the final larval stage (L4). Progressive dendrite morphological changes were observed in these animals over the course of aging ( Figure 1A) . Specifically, the PVD dendrites developed bead-or bubble-like structures along dendrites and were enriched in autophagosomes ( Figure 1B ), which is similar to what was observed in mammalian neurons of neurodegenerative disease models (Menzies et al., 2015) . Cytoskeleton disorganization, such as microtubule instability, has been well documented in neurodegeneration (Wang and Mandelkow, 2016) . We next examined the distribution of polymerized microtubules in PVD dendrites using EMTB::GFP (Richardson et al., 2014) and observed fragmented and discontinued microtubule filaments in aged, but not young, animals ( Figure S1D ). Interestingly, most of these fragmented EMTB::GFP signals appeared to be enriched in the aging-associated bead-/bubble-like structures ( Figure S1D ). Whereas PVD dendrites underwent progressive morphological changes over the course of aging, PVD axons and cell bodies did not display significant bead-or bubble-like structures within the same time frame (Figures S1A and S1B). The distributions of axonal autophagosomes and microtubules were also similar in young and aged animals ( Figures S1C and S1D ).
For quantification of age-dependent PVD dendritic morphological change, an animal was considered as having such change if a total of ten or more bead-or bubble-like structures were observed in more than five PVD functional units (dendritic menorahs; Oren-Suissa et al., 2010) . The number of control animals with dendritic morphological changes significantly increased with age: 30% of them started to show bead-or bubble-like structures on day 5 of adulthood, 50% on day 6, and almost 100% on day 7 ( Figure 1C ), whereas the onset of dendritic morphological changes in these animals preceded animal death by several days ( Figure 1C ). In addition, there was an age-dependent progressive increase in the severity of dendritic morphological changes, quantified as the number of bead-or bubble-like structures in each control animal ( Figure 1D ). Next, we tested whether the morphological changes of PVD dendrites were accompanied by any alteration in PVD function. PVD neurons are responsible for the response to harsh touch applied to the mid-part of the body, where the animal subsequently initiates forward or backward movements Li et al., 2011; Way and Chalfie, 1989) . Activating the touch receptor neurons, including ALM, AVM, PLM, and PVM, by gentle touch can also generate similar behavioral responses (Way and Chalfie, 1989) . To exclude the possible effects of the touch receptor neurons in our behavioral tests, we assessed PVD function in a mec-4 mutant background, which lacks functioning touch receptor neurons but has normally functioning PVD neurons (Driscoll and Chalfie, 1991; Liu and Shen, 2011) . We used mec-3 mutants, which have dysfunctions in both PVD and touch receptor neurons, as a positive control for the ''no harsh touch response'' (Way and Chalfie, 1989) . Consistent with previous observations, approximately 60% of mec-3 mutants did not respond to harsh touch (Liu and Shen, 2011) , a fraction that was consistent over days 1-10 ( Figure 1E ). On the other hand, mec-4 animals, considered to have wild-type responses to harsh touch, showed an age-dependent increase in the ''non-response rate'' ( Figure 1E ), which mirrored the observed PVD morphological changes (bead-or bubble-like structures).
Neurodegeneration is defined as a progressive loss of neurons or their processes (axons and dendrites) with a corresponding progressive impairment in neuronal function (Jack et al., 2013) . Although we did not observe a loss of PVD dendritic menorahs in the time frame we examined ( Figure S1E ), the bead-or bubble-like structures along PVD dendrites, which were enriched with autophagosomes and fragmented microtubules, demonstrated the features of neurodegeneration. Similar beading or blebbing of neurites has been used as a marker of neurodegeneration in both invertebrate and vertebrate models (Kuchibhotla et al., 2008; Morsch et al., 2015; Pan et al., 2011) . Moreover, PVD neurons underwent an aging-associated functional decline that coincided temporally with the morphological changes of their dendrites ( Figure 1E ). Based on this evidence, we conclude that PVD neurons display aging-associated dendrite degeneration at both morphological and functional levels. We thus characterized PVD dendrite degeneration by bead-or bubble-like structures formed along the dendrites (see more details in the STAR Methods section). Given that PVD axons and cell bodies did not show noticeable morphological and structural changes within the same time period (Figures S1A-S1D ), the dendrite degeneration we observed was likely to represent the early stage of PVD neurodegeneration.
(D) The severity of PVD dendrite degeneration in control animals. Each dot represents an individual animal. n = 10$12. One-way ANOVA, followed by Fisher's least significant difference (LSD) post hoc test; #p < 0.05; ##p < 0.001. (E) PVD function analysis in mec-4 mutants as the reference strain and in mec-3 mutants as a positive control for not responding to harsh touch. Data are represented as mean ± SEM. See also Figures S1 and S2.
To further demonstrate that the PVD dendrite degeneration we describe here is associated with aging, we tested whether changing animal lifespan could alter this phenotype. Loss-offunction (lf) in daf-2, the insulin/insulin growth factor (IGF) receptor, can greatly extend the lifespan of C. elegans (Apfeld and Kenyon, 1998) . Consistent with the essential role of daf-2 in aging, we found that a daf-2(lf) mutation significantly delayed the onset of aging-associated PVD dendrite degeneration ( Figure S1F ). daf-2 appeared to regulate aging-associated degeneration in a non-cell-autonomous manner (Figure S1F) , similar to its non-cell-autonomous functions in regulating lifespan (Apfeld and Kenyon, 1998) . These data further support that the PVD dendrite degeneration phenotype is aging associated.
Epidermal NLP-29/AMP Triggers Aging-Associated PVD Dendrite Degeneration Through a genetic screen, we found that an lf mutation (tm1931) in nlp-29 significantly delayed the onset of aging-associated PVD dendrite degeneration at both morphological and functional levels ( Figures 2A-2D and S1B), whereas nlp-29(tm1931) animals had a comparable lifespan to that of control animals (Figure S2A ). To further confirm our observation, we generated a second lf allele, nlp-29(yad90) , in which the coding region of nlp-29 was deleted ( Figure S3A ). nlp-29(yad90) delayed agingassociated PVD dendrite degeneration to the same degree as observed in nlp-29(tm1931) ( Figure 2B ). Expression of NLP-29::GFP under its own promoter with its own 3 0 UTR fully rescued nlp-29(tm1931) phenotypes ( Figure 2E ). nlp-29 is mainly expressed in the epidermis and functions as an AMP to combat infection via the skin (Couillault et al., 2004) . We found that RNAi knockdown of nlp-29 in the epidermis was sufficient to delay aging-associated PVD dendrite degeneration as in nlp-29(lf) mutants, whereas PVD-specific knockdown of nlp-29 did not cause any obvious delay of dendrite degeneration (Figure S3C) . Consistent with these results, expression of nlp-29 using an adult epidermis-specific promoter (Pcol-19) was able to rescue nlp-29(tm1931) phenotypes ( Figure 2E ). With these observations, we conclude that epidermally expressed nlp-29 plays a key role in regulating aging-associated PVD dendrite degeneration.
To further confirm the essential role of NLP-29 in PVD dendrite degeneration, we microinjected synthetic NLP-29 peptide into control animals at day 1 at 10 mM and 100 mM ( Figure 3A) . As a control peptide, we used a highly similar AMP NLP-31 at 100 mM ( Figure S3B ). At 24 hr post-injection (day 2), approximately 45% of animals injected with 10 mM NLP-29 and 60% injected with 100 mM NLP-29 displayed PVD dendrite degeneration, whereas only $25% injected with vehicle (DMSO) or NLP-31 showed dendrite degeneration (Figure 3A) . Similar to what was observed during aging-associated degeneration, we found that autophagosomes were also enriched in degenerating PVD dendrites of NLP-29-injected animals ( Figure S3F ), whereas similar injections did not cause any obvious changes in PVD axons ( Figures S3E and S3F ). In addition, we observed that epidermis-specific overexpression of nlp-29 induced an early onset of aging-associated PVD dendrite degeneration ( Figure 3B ). These data show that overproduction of NLP-29 is sufficient to induce PVD dendrite degeneration. (wdIs51) and nlp-29 (tm1931) mutants on day 7. Zone 2 is same as illustrated in Figure 1A . The scale bars represent 50 mm. *The weak GFP signal in the intestine is gut auto-fluorescence, which is commonly observed in aged animals. Our results led us to hypothesize that aging-associated PVD dendrite degeneration is triggered by age-dependent changes in nlp-29 expression level. Indeed, both nlp-29 mRNA and protein levels increased with age in control animals ( Figures 3C,  3D , and S3D), and the significant increase of nlp-29 expression on day 5 coincided temporally with the dramatic increase in the number of animals with PVD dendrite degeneration over the course of aging. The age-dependent change in epidermal nlp-29 expression was also confirmed by an increase in the number of control animals (nlp-29 transcriptional reporter: frIs7 ; Pujol et al., 2008a) with Pnlp-29::GFP induction during aging ( Figure 3E ).
As C. elegans age, the skin displays structural changes, such as thickened cuticles and thinner epidermis (Herndon et al., 2002) , which could potentially lead to a loss of epidermal integrity and subject aged animals to a higher susceptibility to microbial infections. Under lab culture conditions, C. elegans uses E. coli OP50 as a food source. As OP50 can be pathogenic to older C. elegans (Garigan et al., 2002) , one may argue that changes in epidermal integrity or microbial infections could contribute to the age-dependent increase of nlp-29 expression and PVD dendrite degeneration that we observed. To test these possibilities, we first examined the epidermal integrity using Hoechst 33258 as previously described . By counting the percentage of animals with staining of epidermal nuclei, we found that there was no significant difference in epidermal integrity between day 1 and day 7 control animals (Figures S2B and S2C) . Also, none of the mutations examined in this study seemed to affect epidermal integrity (Figures S2B and S2C) . We further showed that aging-associated PVD dendrite degeneration was unlikely to be associated with microbial infections, as animals grown on dead (heat-killed) OP50 or plates supplemented with anti-fungal drugs (nystatin or amphotericin B) displayed agedependent Pnlp-29::GFP induction and PVD dendrite degeneration to a similar extent as in animals grown under control conditions ( Figures 3E-3H ). During infection, the expression level of nlp-29 is regulated by a conserved innate immune signaling cascade in the epidermis, GFP induction (appear yellow, yellow-green, or green). Student's t test showed no differences between the live OP50 condition and heat-killed OP50 condition at any time point. (F) Age-dependent changes of Pnlp-29::GFP induction in control animals (frIs7) grown on NGM plates supplemented with anti-fungal drugs (either 10 mg/mL nystatin or amphotericin B 1.6 mg/mL). Student's t test showed no differences between drug (À) condition and each drug (+) condition at any time point. (G) PVD dendrite degeneration rate of control animals (wdIs51) grown on live OP50 or heat-killed OP50. Student's t test showed no differences between the two conditions at any time point. (H) PVD dendrite degeneration rate of control animals (wdIs51) grown on NGM plates supplemented with anti-fungal drugs (either 10 mg/mL nystatin or amphotericin B 1.6 mg/mL). Student's t test showed no differences between drug (À) condition and each drug (+) condition at any time point. Data are represented as mean ± SEM. Non-significant comparisons are not indicated in the figure -12(tm1498) , all-tissue as well as PVD-specific rescue strains. The dpy-30 promoter and ser-2(3) promoter were used to express npr-12 cDNA in all tissues and PVD, respectively. One-way ANOVA, followed by Fisher's LSD post hoc, was used to determine the difference between npr-12 and both rescue strains. PVD-specific rescue versus npr-12: #p < 0.05; ##p < 0.001. All-tissue rescue versus npr-12: yp < 0.05; yyp < 0.001. No differences were detected between all-tissue and PVD-specific rescue strains at any time point. (E) PVD dendrite degeneration in nlp-29;npr-12 double mutants. One-way ANOVA showed no differences between nlp-29;npr-12, nlp-29 single mutants, and npr-12 single mutants at any time point. (F) PVD dendrite degeneration in control (wdIs51) and npr-12(tm1498) animals microinjected with 100 mM synthetic NLP-29 peptide. Injection was performed at age of day 1, and PVD dendrite degeneration was examined 24 hr post-injection. Control animals: VEH group: n = 146; NLP-29 group: n = 64. npr-12 mutants: VEH group: n = 46; NLP-29 group: n = 65; n indicates the number of animals. Fisher's exact test; #p < 0.05; 29, NLP-29 peptide. (G) PVD dendrite degeneration induced by nlp-29 OE in npr-12(tm1498) mutants. The col-19 promoter was used to drive nlp-29 OE in the epidermis. One-way ANOVA, followed by Fisher's LSD post hoc test, was used to detect the differences between groups on each day. #p < 0.05. (H) Live-cell surface staining of HEK293T cells co-transfected with GFP and N-terminal FLAG-tagged NPR-12. Cells were stained with anti-FLAG antibody. The scale bars represent 50 mm.
(legend continued on next page) consisting of TIR-1/SARM, NSY-1/MAP3K, SEK-1/MAP2K, and PMK-1/p38 mitogen-activated protein kinase (MAPK) (Dierking et al., 2011; Labed et al., 2012; Pujol et al., 2008a) . We found that loss of function in pmk-1 or tir-1 also delayed aging-associated PVD dendrite degeneration ( Figure S4A ). Double mutants of nlp-29 with tir-1 or pmk-1 did not show a stronger delaying effect when compared to nlp-29(lf) single mutants, suggesting that tir-1, pmk-1, and nlp-29 lie within the same pathway to influence aging-associated PVD dendrite degeneration ( Figure S4B) . A previous study showed that TIR-1 and PMK-1 could function in neurons to regulate neurodegeneration in a C. elegans amyotrophic lateral sclerosis model (Vé riè pe et al., 2015) . We examined the potential neuronal functions of TIR-1 and PMK-1 in aging-associated PVD dendrite degeneration by tissue-specific RNAi. PVD-specific knockdown of TIR-1 or PMK-1 did not affect the onset of PVD dendrite degeneration, whereas knockdown of TIR-1 or PMK-1 in the epidermis delayed PVD dendrite degeneration (Figures S4C [epidermis RNAi] and S4D [PVD RNAi]). These results confirm that the TIR-1-PMK-1 pathway functions in the epidermis, but not in neurons, and does this via controlling nlp-29 expression to regulate PVD dendrite degeneration.
NLP-29 Activates NPR-12, a Neuronal GPCR, to Regulate PVD Dendrite Degeneration PVD dendrites are anatomically sandwiched between the epidermis and body wall muscle (Albeg et al., 2011) . One possibility for how epidermal NLP-29, a small peptide, may communicate with PVD dendrites is through ligand-receptor binding. NLP-29 was initially identified and named for its sequence similarity with YGGWamide neuropeptides (Nathoo et al., 2001) . We hypothesized that the potential neuronal receptor(s) for NLP-29 might be known or predicted neuropeptide receptors. PVD neurons express at least 8 potential neuropeptide receptors: dmsr-1; npr-2; npr-12; npr-32; pdfr-1; C17H11.1; lat-1; and T21H3.5 (Frooninckx et al., 2012; Smith et al., 2010) . We tested all these receptors and found that two npr-12(lf) alleles had aging-associated PVD dendrite degeneration patterns comparable to that of nlp-29 mutants, whereas mutating or knocking down other neuropeptide receptors did not reproduce the degeneration-delaying effect of nlp-29(lf) ( Figures 4A, 4B , S1B, S5A, and S5B). NPR-12, an ortholog of human pyroglutamylated RFamide peptide receptor, is an orphan GPCR predicted to have a neuropeptide Y receptor-like activity (Frooninckx et al., 2012) . We confirmed the expression of npr-12 in PVD neurons, including the cell body, dendrites, and axons, using npr-12 transcriptional and translational reporter strains (Pnpr-12::GFP, Pnpr-12::NPR-12::GFP; Figures S5C and S5D ). The delayed onset of PVD dendrite degeneration in npr-12 mutants was also accompanied by a delayed onset of aging-associated PVD dysfunction (Figure 4C) . Unlike nlp-29, no age-dependent changes of npr-12 expression were observed in control animals ( Figure S5E ). PVD-specific knockdown of npr-12 delayed the onset of PVD dendrite degeneration as in npr-12(lf) mutants, whereas epidermis-specific knockdown did not ( Figure S5F ). Both ubiquitous and PVD-specific expression of npr-12 cDNA were able to rescue the PVD dendrite degeneration phenotype in npr-12(tm1498) mutants to similar extents ( Figure 4D ). These results suggest that npr-12 functions cell autonomously to regulate PVD dendrite degeneration.
Next, we demonstrated that nlp-29 and npr-12 acted in the same genetic pathway by showing that npr-12;nlp-29 double mutants did not display an enhanced PVD dendrite degeneration-delaying effect when compared with the single mutants of nlp-29 and npr-12 ( Figure 4E ). Moreover, we showed that npr-12(lf) blocked PVD dendrite degeneration induced by synthetic NLP-29 peptide microinjected into young adults ( Figure 4F ). Similarly, npr-12(lf) was also able to suppress the early onset PVD dendrite degeneration induced by epidermal nlp-29 overexpression ( Figure 4G ). Collectively, this evidence indicates that NPR-12 acts downstream of NLP-29.
To test whether NPR-12 is a functional receptor for NLP-29, we transiently transfected HEK293T cells with a plasmid containing C. elegans npr-12 cDNA. Cell surface expression of NPR-12 modified with an N-terminal FLAG tag was confirmed by live-cell surface immunochemistry staining ( Figure 4H ). NPR-12 is an orphan GPCR, and no previously published information is available regarding its coupled G protein. Therefore, we conducted experiments by co-expressing NPR-12 and the promiscuous G protein Ga15, which couples with many GPCRs and leads to intracellular calcium release when activated (Offermanns and Simon, 1995) . We stimulated HEK293T cells transiently expressing NPR-12, Ga15, and GCaMP6s with a perfusion solution containing 10 mM synthetic NLP-29. We found that stimulation of the NPR-12-transfected cells with 10 mM NLP-29 induced a significant elevation of calcium, whereas the solvent-only control did not cause any changes ( Figures 4I, 4J , and S6C-S6G). To further test the specificity of this response, we examined the effect of NLP-29 on NPR-32, another GPCR expressed in PVD neurons, and the human beta2-adrenergic receptor (b2-AR), also a GPCR. In this assay, NLP-29 failed to elicit a significant response in NPR-32-or b2-AR-expressing cells ( Figures 4I, 4J , S6A, S6B, and S6I-S6P). We stimulated NPR-12-expressing cells with NLP-31, an AMP closely related to NLP-29 in C. elegans, and no response was observed either (Figures 4I, 4J, and S6H) . Altogether, through genetic analysis of npr-12(lf) phenotypes, functional analysis of npr-12(lf)'s ability to suppress NLP-29-induced PVD dendrite degeneration, and examination of ligand-receptor interactions in vitro, we conclude that NPR-12 is the receptor for NLP-29 in mediating aging-associated PVD dendrite degeneration. Autophagic Machinery Acts Downstream of NPR-12 in PVD Dendrite Degeneration Accumulation of autophagosomes and late autophagic vacuoles in the distal dendrites/axons of degenerating neurons has been well documented in mammals (Feng et al., 2017; Yu et al., 2005) . As described earlier, we also showed autophagosomes were enriched in degenerating PVD dendrites during aging (Figure 1B) , raising the possibility that activation of NPR-12 may recruit the autophagic machinery to trigger PVD dendrite degeneration. Supporting this assumption, we found that co-injection of bafilomycin A1 (Baf A1), an autophagy inhibitor (Zhang et al., 2015) , was able to suppress the induced-PVD dendrite degeneration in NLP-29-peptide-injected animals ( Figure 5A ). To further confirm the function of autophagy in aging-associated PVD degeneration, we examined mutants affecting different steps of the autophagy pathway, including atg-3, atg-4.1, and epg-5. ATG-4.1 cleaves the ubiquitin-like protein LGG-1 to generate a functional form LGG-1-I that can further conjugate with phosphatidylethanolamine via ATG-3 and other sequential actions to form autophagosomes (Wu et al., 2012 ). EPG-5 is then subsequently required for the fusion of autophagosomes and lysosomes to form degradative autolysosomes (Lu et al., 2011) . As shown in Figure 5B , mutations in atg-3, atg-4.1, and epg-5 caused similar delays of PVD dendrite degeneration onset as those in nlp-29 and npr-12 mutants. To address the genetic interactions between autophagy, nlp-29 and npr-12, we further analyzed atg-4.1(lf) mutants. atg-4.1(lf) delayed the aging-associated PVD dendrite degeneration at both morphological and functional levels ( Figures 5B-5D and S1B), whereas the mutant animals had a comparable lifespan to that of the controls (Figure S2A) . The double mutants atg-4.1;nlp-29 or atg-4.1;npr-12 exhibited the same degree of PVD dendrite phenotypes as those in single mutants ( Figure 5E ). Also, atg-4.1(lf) suppressed the early PVD dendrite degeneration caused by epidermal nlp-29 overexpression ( Figure 5F ). Moreover, PVD-specific rescue of atg-4.1 could restore the delayed PVD dendrite degeneration in atg-4.1(lf) mutants ( Figure 5G ). Collectively, these results indicate a cell autonomous involvement of the autophagic machinery in nlp-29-npr-12-regulated PVD dendrite degeneration.
NLP-29 and NPR-12 Regulate Dendrite Degeneration in
Other C. elegans and Mammalian Neurons npr-12 is expressed in neurons other than PVD as well (Figure S5D) , such as the epidermis-associated head sensory FLP neurons (Albeg et al., 2011) . Over the course of aging, FLP dendrites in control animals (yadEx650 (Pmec-3::GFP)) displayed progressive degeneration and loss of function in nlp-29 and npr-12 significantly delayed the onset of FLP dendrite degeneration ( Figures 6A and 6B) . Similar to what was observed in PVD neurons, nlp-29 functioned in the epidermis and npr-12 acted cell autonomously to regulate FLP dendrite degeneration (Figure 6B) . Next, we examined the degeneration-triggering function of nlp-29 and npr-12 in posterior sensory PLM neurons, which are embedded in the epidermis but do not endogenously express npr-12. In control animals, PLM sensory processes/dendrites showed mild to moderate progressive degeneration over the course of aging ( Figures 6C and 6D ), whereas animals with PLM ectopically expressing npr-12 had a significantly earlier onset of degeneration ( Figure 6D) . Importantly, the nlp-29(lf) mutation was able to block this additional effect and bring the degeneration rate back to the control level ( Figure 6D ). Furthermore, we tested whether direct access to the epidermis was required for NPR-12 to receive NLP-29 in regulating dendrite degeneration. To do this, npr-12 was ectopically expressed in amphid sensory neurons, which have dendrites surrounded by glial cells. As shown in Figures S5G and S5H , amphid sensory neurons of control animals (yadEx1037(Parl-13::GFP)) displayed very slight dendrite degeneration over the course of aging, demonstrated by beading or forming vacuoles along the dendrites. We found that ectopic expression of npr-12 did not further increase the dendrite degeneration rate in amphid neurons ( Figure S5H ), suggesting that direct access to epidermal NLP-29 is likely critical for neuronal NPR-12 to transmit degeneration signals.
In addition, we tested the ability of NLP-29 and NPR-12 in regulating mammalian dendrite degeneration using cultured rat cortical neurons. As shown in Figure 6E , treating NPR-12-expressing cortical neurons with NLP-29 induced significant dendrite degeneration, which appeared gradually over the time with the presence of NLP-29 ( Figure S6Q ), whereas NLP-29 by itself did not show neuronal toxicity ( Figure 6F ). Degeneration was not observed in NPR-12-expressing cortical neurons treated with the control peptide NLP-31 ( Figures 6E, 6F, and  S6R) . Similar to what was found in C. elegans neurons, inhibition of the autophagy pathway with bafilomycin A1 prevented NLP-29/NPR-12-induced degeneration in rat cortical neurons (Figures 6G and 6H) . Unlike in C. elegans neurons, we observed that NLP-29-treated NPR-12-expressing rat cortical neurons not only had bead-or bubble-like structures along their dendrites but also a loss of dendritic branching, further supporting the significance of the NLP-29-NPR-12-autophagy pathway in regulating neurodegeneration. Although the reason for the lack of dendritic loss in aged C. elegans neurons is still unclear, it is possible that some signals involved in dendritic pruning during aging may be absent in nematodes.
Taken together, these results show that NLP-29 and NPR-12 can mediate dendrite degeneration in other C. elegans neurons as well as in mammalian neurons, in support of an evolutionarily conserved function of AMPs and their neuronal receptors in regulating dendrite degeneration.
Fungal Infection Induces Dendrite Degeneration via NLP-29 and NPR-12
NLP-29 has been characterized as an AMP (Couillault et al., 2004) , whereas our study reveals its unexpected role in dendrite degeneration. This raises the question as to whether NLP-29 has functions in both fighting pathogens and inducing dendrite degeneration during infection. To address this question, we infected animals with a nematode fungal pathogen Drechmeria coniospora, which is known to trigger an immune response and induce the expression of AMPs, including nlp-29 in C. elegans (Pujol et al., 2008b) . 36-hr exposure to Drechmeria coniospora on day 1 induced a 6-fold increase of nlp-29 mRNA expression in control animals but did not change npr-12 mRNA expression ( Figures S7B and S7C) . We found that infection of day 1 animals caused significant PVD dendrite degeneration, whereas control treatment did not induce any obvious phenotypes ( Figure 7A ). Microbe-associated molecular patterns (MAMPs) are molecules associated with certain microbial groups, can be recognized by hosts to trigger innate immune responses, and, in some cases, do so without harming the host cells (Chu and Mazmanian, 2013) . Although it is not clear whether or which MAMPs can be detected by C. elegans (Luallen and Troemel, 2014) , we treated control animals with heat-killed D. coniospora to exclude the possibility of D.-coniospora-associated MAMPs causing the dendrite degeneration phenotype. As shown in Figures S7D and S7E , 36-hr exposure of heat-killed D. coniospora did not increase nlp-29 expression or cause PVD dendrite degeneration in day 1 control animals, suggesting that D.-coniospora-induced PVD degeneration is not associated with MAMP stimulations.
We then found that nlp-29(lf), npr-12(lf) , and atg-4.1(lf) were able to completely block the infection-induced PVD dendrite degeneration ( Figure 7A ). Compared to aging-associated degeneration, the rate of degeneration induced by infections is relatively low. This may be due to protective mechanisms in young animals, as infection of older animals caused more severe phenotypes ( Figure 7B ). We also examined whether fungal infection would affect other C. elegans neurons. As shown in Figure 7C , in infected animals, FLP dendrites displayed significantly higher degeneration rates when compared to the ''non-infected'' group. Furthermore, nlp-29(lf) and npr-12(lf) mutations blocked the FLP degeneration caused by infection ( Figure 7C ). Interestingly, infection did not induce obvious degeneration of PLM dendrites/sensory processes, which did not express npr-12 endogenously ( Figure 7D ). However, ectopic expression of npr-12 in PLM neurons was sufficient to cause infection-dependent degeneration, whereas nlp-29(lf) substantially suppressed this effect ( Figure 7D ). These results suggest that NLP-29 can function in both fighting pathogens and triggering dendrite degeneration, and in dendrite degeneration, the function of NLP-29 relies on the expression of its neuronal receptor NPR-12.
DISCUSSION
Using C. elegans PVD neurons as a model, we investigate the molecular mechanisms underlying aging-and infection-associated dendrite degeneration. During aging, PVD dendrites display progressive degeneration. As a result, most aged animals lose their responses to harsh touch, a function mediated by PVD neurons. We find that loss of function in an epidermally expressed AMP NLP-29 suppresses the aging-associated PVD dendrite degeneration. Consistent with this finding, the expression level of nlp-29 is positively correlated with age and increasing NLP-29 is sufficient to cause PVD dendrite degeneration in young adult animals. Moreover, we identify the GPCR NPR-12 in the PVD neuron as the receptor for NLP-29, and the autophagy pathway acts downstream of NPR-12 in mediating aging-associated PVD dendrite degeneration ( Figure S7I) . We further present evidence to show that the NLP-29-NPR-12 regulation is also involved in infection-associated dendrite degeneration. The function of AMPs and their neuronal receptors in dendrite degeneration appears to be evolutionarily conserved, as NLP-29/AMP can trigger dendrite degeneration in NPR-12-expressing rat cortical neurons as well.
Besides the bead-/bubble-like structures found in aging PVD dendrites, we also observe age-dependent changes of dendritic organization/branching (Figures S7F-S7H ). However, these changes appear irrelevant to the functional aging of PVD neurons, as a mutation in nlp-29, npr-12, or atg-4 .1 strongly delays the functional decline of PVD in aging without affecting the aging-associated changes in dendritic organization/branching ( Figures S7G and S7H ). On the other hand, the aging-associated bead-or bubble-like structures along dendrites that we observe are tightly linked to the functional aging of PVD neurons. In fact, these structures are also documented in degenerating neurons from fruit flies to rodents as well as in patients with neurodegenerative diseases (Greenwood et al., 2007; Su et al., 1993; Tao and Rolls, 2011) ; therefore, they appear to be evolutionarily conserved features of neurodegeneration. Although the components/molecular features of the bead or bubble-like structures are still unclear, we show that autophagosomes and fragmented microtubules are enriched in these structures along the dendrites and the autophagy pathway plays important roles in their formation. Further studies on the mechanisms underlying the induction of such bead-/bubblelike structures may provide insights into how neurodegeneration is initiated.
Whereas PVD dendrites undergo progressive aging-associated degeneration over the first 9 days, PVD axons do not show significant degeneration during the same time period, suggesting the aging-associated dendrite and axon degeneration use distinct mechanisms in C. elegans. PVD neurons have complex dendritic branches and a single axon; the tertiary and quaternary dendrites are in association with the epidermis (Oren-Suissa et al., 2010) , whereas the axons run in the ventral nerve cord and are separated from the epidermal tissues (White et al., 1976 (White et al., , 1986 . As NPR-12 is expressed in both PVD dendrites and axons, it seems that epidermally released NLP-29/ AMP can only function locally to affect PVD dendrites, whereas PVD axons are less affected due to their anatomical position. This conclusion is further supported by the results from examining the degeneration of PLM and amphid sensory neurons. Namely, expression of NPR-12 in epidermis-associated PLM neurons induces NLP-29-dependent aging-associated degeneration, whereas expression of NPR-12 in amphid neurons, which are not associated with epidermis, did not affect their degeneration. However, injection of NLP-29 in young animals only causes degeneration in the PVD dendrite, but not in the axons, suggesting additional protective mechanisms may be involved.
In this study, we show that NLP-29/AMP and its neuronal receptor can function in both aging-and infection-associated dendrite degeneration, which again raises the question as to whether there indeed are connections between infection and the pathogenesis of aging-related neurodegenerative diseases. Whereas the current evidence for such connections remains limited, a classical example of infection-induced neurodegeneration in humans would be HIV-associated dementia, as studies have suggested that direct exposure to HIV-1 or indirect damage through toxic substances released by infected or immune-stimulated microglia and astrocytes may cause neurotoxicity (Kaul et al., 2005) . Amyloid beta (Aß) has long been implicated in AD, and its expression level increases with age in cognitively intact human subjects as well (Lesné et al., 2013) . Recent studies have demonstrated that soluble Aß oligomers can bind to microbes, functioning as AMPs (Kumar et al., 2016) . Given these parallels between NLP-29 and Aß, our data further provide mechanistic evidence for infection-related AMPs mediating neurodegeneration during aging.
The essential function of epidermally expressed AMP NLP-29 in neurodegeneration we report here reveals a critical role of epidermal cells in regulating neuronal aging, which joins emerging evidence of non-cell-autonomous mechanisms of neurodegeneration (Garden and La Spada, 2012; Ilieva et al., 2009 ). The epidermis is considered to function as the skin of C. elegans, but recent studies also show that epidermal cells can play similar roles as glial cells/neuronal support cells to regulate dendrite development, synapse formation, and neuronal activity (Dong et al., 2013; Salzberg et al., 2013; Shao et al., 2013; Stawicki et al., 2011) . Glial cells/neuronal support cells have been implicated in the pathogenesis of neurodegenerative diseases. Interestingly, some AMPs are highly expressed in mouse microglia (Hickman et al., 2013) and astrocytes of AD patients (Williams et al., 2013) in the absence of infections. Therefore, the AMP-mediated non-cell-autonomous signaling from neuronal support cells may be evolutionarily conserved for neuronal aging.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
C. elegans Strains and Maintenance C. elegans strains were maintained on NGM plates at 20 C as described previously (Brenner, 1974) , and only hermaphrodites were used for experiments. For all aging-associated experiments, adults were bleach treated to kill possible pathogenic microbes and to yield age-synchronized animals. Then hermaphrodites of L4 stage were picked and grown on NGM plates with 5 0 -flurodeoxyuridine (FUDR) to inhibit progeny growth. Day 1 adulthood was defined as in 24 hours after L4 stage. Dead E. Coli OP50 was prepared by heating at 100 C for 30 min. For experiments with anti-fungal drugs, 10 mg/mL (final concentration) nystatin or 1.6 mg/mL (final concentration) amphotericin B was supplemented in NGM plates. All transgenes and strains are described in Table S1 . nlp-29(yad90) allele was generated using CRISPR by co-injecting plasmids expressing two probes: CAGGAGGATATGGAGGATA and TCCATATCCCCATTGTGCGC.
Cell Cultures HEK293T cells were maintained in minimal essential medium (Sigma) containing 10% fetal bovine serum (Sigma) with penicillinstreptomycin and amphotericin B.
Rat cortical neurons were purified from postnatal day 1 Sprague-Dawley rat pups (Charles River Laboratories) of both sexes by sequential immunopanning and cultured in serum-free medium containing BDNF, CNTF, and forskolin on laminin-coated coverslips as previously described (Risher et al., 2014) . All experiments were conducted in accordance with the Duke University Institutional Animal Care and Use Committee guidelines (IACUC Protocol Numbers A173-14-07 and A147-17-06).
METHOD DETAILS
DNA Constructs and Generation of Transgenes All DNA expression constructs were made using Gateway cloning technology (Invitrogen). Sequences of the final clones were confirmed. The information for each construct is in Table S1 . Primer sequences are available upon request. Transgenic animals were generated following standard procedures (Mello et al., 1991) . In general, plasmid DNAs of interest were used at 10-100ng/ml with the co-injection marker Pttx-3::RFP or Pttx-3::GFP at 50ng/ml. For each construct, two to five independent transgenic lines were analyzed. Table S1 lists genotypes and DNA constructs for transgenes.
Transfection HEK293T cells were plated on poly-D-lysine-coated 35 mm glass-bottom dish (MatTek) and transfected with plasmids coding for GCaMP6s, mouse Ga15, along with FLAG-NPR-12, FLAG-NPR-32 or human b2-AR using Lipofectamine 2000 (Invitrogen).
The rat cortical neurons were transfected using the Lipofectamine LTX (Invitrogen) reagent on days in vitro 6 (DIV6) with plasmids coding NPR-12-2A-GFP or GFP only. At DIV 9, the transfected neurons were treated with NLP-29 or NLP-31 peptide at 10 mM final concentration, and the peptides were present in the culture thereafter for 3 days.
Fluorescence Microscopy
We scored fluorescent reporters in live animals using a Zeiss Axio Imager 2 microscope equipped with Chroma HQ filters. Confocal images were collected of animals immobilized by 1% 1-phenoxy-2-propanol (TCI America) in M9 buffer using a Zeiss LSM700 confocal microscope. Pictures shown in the figures are projections of z stack images (1 mm/section). GFP-expressing rat cortical neurons were imaged at DIV 12 with Zeiss Axioimager M1 Epifluorescence Microscope (Carl Zeiss) using a 20X objective.
Quantification of Dendrite Degeneration
In this study, dendrite degeneration in C. elegans was characterized as bead or bubble-like structures along the neuron processes, and was quantified under 63X magnification. wdIs51 (F49H12.4::GFP) (Smith et al., 2010), zdIs5 (Pmec-4::GFP) (Clark and Chiu, 2003) , and yadEx650 (Pmec-3::GFP) were used to visualize PVD, PLM, and FLP neurons, respectively. An animal was considered to be undergoing PVD dendrite degeneration if a total of ten or more bead or bubble-like structures were observed in more than five PVD functional units (menorahs) (Oren-Suissa et al., 2010) . For the severity of PVD dendrite degeneration, the number of bead or bubble-like structures along PVD dendrites (the entire dendritic tree of either PVDL or PVDR) was counted for each animal. An animal was considered to be undergoing FLP dendrite degeneration if five or more bead or bubble-like structures were observed along the dendrites. For PLM neurodegeneration, the quantification was focused on anterior processes/dendrites. An animal was considered to be undergoing PLM degeneration if five or more of bead or bubble-like structures were observed. For amphid sensory neurons, an animal was considered to be undergoing dendrite degeneration if five or more bead/bubble-like structures were observed, or if one or more vacuoles that have a larger diameter than the dendrites were observed along dendrites. For each time point, independent experiments were performed three times, each consisting of at least 50 live animals. The percentage was calculated by dividing the number of animals having dendrite degeneration by the total number of animals observed. The error bar indicates ± SEM among the three experiments at each time point. Also, a small number (z15 animals) of control animals were always observed in parallel to non-control animals in each subsequent dendrite degeneration experiment, to ensure the experimental conditions were appropriate and that the % control animals having dendrite degeneration deviated less than 5% from the mean number (for each day) in Figure 1C . Quantification of dendrite degeneration in C. elegans was performed without applying any anesthetics.
For degenerative morphological changes in rat cortical neurons, Sholl analysis was performed using a plug-in for Fiji as described previously .
Quantification of dendrite degeneration was also performed double blind.
Adult Epidermal or PVD-specific RNAi
To knock down gene expression in the adult epidermis or PVD, we expressed sid-1(cDNA) under the control of Pdpy-7(epidermis) or Pser-2(PVD) in an sid-1 (pk3321) mutant background. sid-1 mutants are resistant to RNAi, and transgenic animals are resistant to RNAi in all tissues except in the cells expressing sid-1 cDNA. At the L4 stage, we transferred transgene animals to RNAi plates (with FUDR) with bacteria expressing the appropriate double-stranded RNA (dsRNA), and we quantified the degeneration of PVD neurons on each day until Day 9. The RNAi clones were obtained from the Ahringer library and confirmed by sequencing or made by PCR from cDNA. Bacteria expressing empty L4440 plasmid were used as control.
Protein Analysis
For protein expression studies in C. elegans, we used an integrated transgene (yadIs58) expressing NLP-29::GFP::2A::mCherry driven by its own promoter with its own 3 0 UTR (pNP140). Synchronous animals were grown on NGM plates with 5 0 -flurodeoxyuridine (FUDR), and animals were collected at days 1, 3, 5 and 7. Protein was extracted in SDS sample buffer containing 1mM DTT by freezethawing for 20-50 cycles between dry ice/ethanol and a 37 C water bath, and then denatured by heating to 95 C for 5 minutes. Blots were probed with a rabbit anti-GFP antibody (Sigma, G1544), or a mouse anti-tubulin monoclonal antibody (Life Technologies, 322600), and visualized with Amersham HRP-conjugated anti-rabbit or anti-mouse secondary antibodies at a 1:5000 dilution (GE Healthcare Life Sciences) using the SuperSignal West Femto kit (Pierce, Rockford, IL).
Real-time Reverse Transcription PCR
To measure the change in nlp-29 mRNA levels during aging, total RNA was isolated from wild-type N2 animals at ages of Day 1, Day 3, Day 5 and Day 7. Animals were washed with M9 buffer three times for 90 minutes in total, and RNA was isolated using TRI Reagent (Invitrogen). Collection of animals was repeated three independent times for each time point. Reverse transcription was performed on total RNA (1 mg) using an iScript Reverse Transcription Supermix for RT-qPCR (Bio-Rad Laboratories). Quantitative real-time, reverse-transcription PCR (qPCR) was performed using iTaq Universal Probes Supermix (Bio-Rad Laboratories) and ready-to-use TaqMan Gene Expression Assays (Invitrogen) to quantify the mRNA levels of nlp-29, npr-12, act-2, ama-1 and cdc-42 . act-2/actin, ama-1/RNA polymerase II and cdc-42/cell division control protein 42 served as internal controls. qPCR amplifications were performed using an Applied Biosystems StepOnePlus Real-Time PCR System (Applied Biosystems). Relative mRNA levels were quantified using StepOnePlus Software v2.1 based on the comparative DDCT method.
Peptide Microinjection
We chemically synthesized the predicted mature NLP-29 peptide of 51 amino acids: QWGYGGYGRGYGGYGGYGRGMY GGYGRGMYGGYGRGMYGGYGRGMYGGWGK (Thermo Scientific); the same was conducted for the NLP-31 peptide of 53 amino acids: QWGYGGYGRGYGGYGGYGRGYGGYGGYGRGYGGYGRGMYGGYGRPYGGYGWGK. 1 mg of peptide was initially dissolved in 100% DMSO to make a stock concentration of 5 mM. The stock was diluted using a 50% v/v solution of DMSO in M9 buffer, to make a final concentration of 10 mM or 100 mM for injection. The 50% DMSO was used as a vehicle solution for the control group. The peptide was injected from the dorsal side, aimed slightly anterior to the PVD cell body to ensure that the cell body was not disturbed. 24 hours post injection, PVD dendrite morphology was examined. For each group, at least 50 animals were injected with either the peptide or vehicle.
Live-cell Immunohistochemistry Staining
Live-cell staining was performed as previously described (Saito et al., 2004) , to visually confirm the expression and localization of FLAG-NPR-12 and FLAG-NPR-32 on the plasma membrane of HEK293T cells. The anti-FLAG antibody was purchased from Sigma (#F3165) and Alexa FluorÒ594-conjugated secondary antibody was purchased from Thermo Fisher Scientific (#A11005).
Live-cell Calcium Imaging 24 hours post transfection, cells were imaged consecutively in three-second intervals using a Zeiss AxioObserver 1.0 inverted microscope. Cells were continuously perfused with bath solution (Hank's buffer containing 10 mM HEPES and 5 mM glucose) using a peristaltic pump, except for the one-minute stimulus period when 10 mM NLP-29 peptide, 10 mM NLP-31 peptide, 16.7% DMSO (the same concentration of DMSO as in the 10 mM peptide solution), or 1 mM isoproterenol solution was applied manually to the recording chamber. The stimuli were diluted using the perfusion buffer. For each dish, all clear single cells were selected as regions of interest, ranging between 95 to 145 cells in each field. Changes in calcium-dependent fluorescence intensity were quantified by calculating the DF/F 0 ratios during the first 120 s post-stimulus. F 0 corresponds to the first frame after stimulus, whereas DF correspond to the difference in fluorescence intensity between F 0 and each individual frame during the first 120 s post-stimulus. The magnitude of the calcium response was also quantified by integrating the area under the response curve during the first 120 s post-stimulus. All data analysis was done with MetaFluor, Microsoft Excel, and Graphpad Prism.
Mortality Assay
All mortality assays were performed at 20 C on NGM plates with FUDR. An experimental pool of at least 50 animals was used for each genotype. Dead animals were counted daily until no animals survived. Lost animals were subtracted from the total number. The experiment was repeated three independent times.
Pnlp-29::GFP Scoring
To quantify frIs7 induction during aging, hermaphrodites of L4 stage were picked and grown on NGM plates with FUDR to inhibit progeny growth. Each animal was scored as uninduced (red or orange) or induced (yellow, yellow-green, and green) at each time point to estimate the percentage induction in a population. The percentage was calculated by dividing the number of animals with Pnlp-29::GFP induction by the total number of animals observed. Three independent experiments were performed, and a total of at least 100 animals were analyzed for each time point. The Pcol-12 promoter was used to drive epidermisspecific expression of dsRed.
Drechmeria Coniospora Infection
Infection was performed as previously described (Pujol et al., 2008a) . Briefly, D. coniospora was freshly harvested in 50 mM NaCl to make a solution, and 150 ml of this solution was added to NGM plates (with regular OP50 and without FUDR) containing animals to be
